SC 13G Filing

Company

Viridian Therapeutics, Inc.\DE

Filed

May 31, 2022

Accession Number

0001273087-22-000073

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →